数据链接：
官方服务：
资源简介：
Average cost of antidepressants in Italy from 2014 to 2023 (in euros per DDD)
应用场景：
相关数据集
Supplementary materials: Cost–effectiveness and cost–benefit analysis of oliceridine in the treatment of acute pain
These are peer-reviewed supplementary tables for the article ' Cost–effectiveness and cost-benefit analysis of oliceridine in the treatment of acute pain ' published in the Jo
DataCite Commons2026-04-29 更新180
Input parameters for the base-case analysis.
Background Expanding the indication of already approved immuno-oncology drugs presents treatment opportunities for patients but also strains healthcare systems. Cost-based pricing models are discussed
NIAID Data Ecosystem50
Results of scenario analyses for sCRT population.
Objective The effectiveness of sugemalimab vs. placebo in post-chemoradiotherapy patients with locally advanced, unresectable stage III NSCLC has been demonstrated and approved by China National Medic
NIAID Data Ecosystem20
A cost-effectiveness analysis of second-generation antihistamine 1 receptor blockers and Japanese kampo shoseiryuto for treatment of perennial allergic rhinitis in outpatient settings in Japan
Objectives: Perennial allergic rhinitis (PAR) is common in Japan. Second-generation antihistamines (SGAs) are commonly used for its treatment; however, it remains unclear which SGA is the most cost
DataCite Commons2025-04-01 更新60
Using Penalized Synthetic Controls on Truncated data: A Case Study on Effect of Marijuana Legalization on Direct Payments to Physicians by Opioid Manufacturers
Amid increasing awareness regarding opioid addiction, medical marijuana has emerged as a substitute to opioids for pain management. Concurrently, opioid manufacturers are putting significant research
Taylor & Francis Group2024-11-19 更新40
